Article info
PDFORIGINAL ARTICLE
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma
- Address correspondence and reprint requests to: Nicola Gebbia, MD, Operative Unit of Medical Oncology, Department of Oncology, Università degli Studi di Palermo, Via del Vespro 127, 90127 Palermo, Italy. Email: chemotherapy{at}inwind.it
Citation
A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma
Publication history
- First published January 1, 2006.
Online issue publication
March 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2006 Blackwell Publishing Ltd.